PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia [9]

Leukemia

Volumn 19, Issue 5, 2005, Pages 888-889

  Passamonti, F ^a   Pietra, D ^a   Rumi, E ^a   Arcaini, L ^a   Della Porta, M G ^a   Malcovati, L ^a   Pascutto, C ^a   Lazzarino, M ^a   Cazzola, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HYDROXYUREA; INTERFERON; MESSENGER RNA; PIPOBROMAN; PROTEIN PRV 1; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HEALTH STATUS; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NONPARAMETRIC TEST; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THROMBOCYTE COUNT; THROMBOCYTHEMIA; TREATMENT OUTCOME;

EID: 18644374272     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403700     Document Type: Letter

References (7)

1. Caruccio L, Walkovich K, Bettinotti M, Schuller R, Stroncek D. CD177 polymorphisms: correlation between high-frequency single nucleotide polymorphisms and neutrophil surface protein expression. Transfusion 2004; 44: 77-82.
2. Temerinac S, Klippel S, Strunck E, Roder S, Lubbert M, Lange W et al. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood 2000; 95: 2569-2576.
3. Passamonti F, Pietra D, Malabarba L, Rumi E, Della Porta MG, Malcovati L et al. Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders. Br J Haematol 2004; 126: 650-656.
4. Gohring K, Wolff J, Doppl W, Schmidt KL, Fenchel K, Pralle H et al. Neutrophil CD177 (NB1 gp, HNA-2a) expression is increased in severe bacterial infections and polycythaemia vera. Br J Haematol 2004; 126: 252-254.
5. Tefferi A, Lasho TL, Wolanskyj AP, Mesa RA. Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood 2004; 103: 3547-3548.
6. Fruehauf S, Topaly J, Villalobos M, Veldwijk MR, Laufs S, Ho AD. Quantitative real-time polymerase chain reaction shows that treatment with interferon reduces the initially upregulated PRV-1 expression in polycythemia vera patients. Haematologica 2003; 88: 349-351.
7. Teofili L, Martini M, Guidi F, Venditti D, Leone G, Larocca ML. The PRV-1 gene expression in essential thrombocythemia. Blood 2004; 104: 2995-2996.